Mark W. Womack is an organization builder with a track record of delivering unprecedented growth and profit in every role. Mark has been the CEO of BioCina since March, 2023, and has rapidly grown BioCina to be the largest CDMO in Australia. Prior to BioCina, Mark was CEO of KBI Biopharma and Selexis, as well as Stelis Biopharma and CBO for AGC Biologics. Prior to joining AGC Biologics, Mr. Womack served over 20 years as a management consulting industry leader and C-level client advisor, guiding many of the world’s renowned companies to achieve record highs in revenue and profit.